DELIVERY LOCATION
560076
DELIVERY LOCATION
560076
  1. Home >
  2. Medicine Info >
  3. Mignar 25 mg Tablet
Mignar 25 mg Tablet by Glenmark Pharmaceuticals Ltd.Mignar 25 mg Tablet by Glenmark Pharmaceuticals Ltd.Mignar 25 mg Tablet by Glenmark Pharmaceuticals Ltd.

Mignar 25 mg Tablet

Mignar 25 mg Tablet by Glenmark Pharmaceuticals Ltd.
Loading images...
Manufacturer
Glenmark Pharmaceuticals Ltd.
Composition
Miglitol
Prescription
Required
15 TABLET ( 15 / STRIP )
₹146.80
₹183.50
(20% off)
Buy Now
Add to cart
Offers
Rs. 50 OFF
Auto applies at the time of payment
Use code: PRACTO & get 40% OFF
40% OFF = 25% OFF + 15% Cashback.
Valid on 1st order on prescription medicines only in September. *T&C apply.
Offers
Rs. 50 OFF
Auto applies at the time of payment
Use code: PRACTO & get 40% OFF
40% OFF = 25% OFF + 15% Cashback.
Valid on 1st order on prescription medicines only in September. *T&C apply.
15 TABLET ( 15 / STRIP )
₹146.80
₹183.50
(20% off)
Buy Now
Add to cart

Description

Mignar 25 mg Tablet is an antidiabetic used in the treatment of type 2 diabetes for adults. This medicine is not recommended for use in children. It may be used in combination with other antidiabetic medicines. Patients are advised to follow strict diet and exercise regimens along with this medicine to get the best possible effect.

Uses of Mignar 25 mg Tablet

What is it prescribed for?

  • Diabetes Type 2

    Mignar 25 mg Tablet is used to control blood sugar levels in adult patients with type 2 diabetes.

Side effects

Major & minor side effects for Mignar 25 mg Tablet

  • Confusion
  • Dizziness and lightheadedness
  • Weakness
  • Shakiness or unsteady walking
  • Increased bowel movementssevere
  • Stomach and abdominal painsevere
  • Excessive air or gas in stomachsevere
  • Rash
SEVERE
Contact your doctor immediately if any of these symptoms are experienced on a regular basis.
RARE
Observed in a small fraction of population.
This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.

Highlights

Commonly asked questions for Mignar 25 mg Tablet

Onset of action

The amount of time required for this medicine to show its action is approximately 1 hour.

Duration of effect

The time until which this medicine remains active in the body is not clinically established.

Safe with alcohol?

moderate
Consumption of alcohol is not recommended during treatment with Mignar 25 mg Tablet due to the increased risk of both low as well as high blood sugar levels. If your diabetes is controlled, moderate consumption of alcohol does not affect sugar levels. However, it is advised that you consult your doctor about all the potential risks and benefits of consuming alcohol during treatment with this medicine.

Is it habit forming?

No habit forming tendency has been reported.

Usage in pregnancy?

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Usage while breast-feeding?

This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

Substitutes

List of substitutes for Mignar 25 mg Tablet

Below is the list of medicines, which have the same composition, strength and form as Mignar 25 mg Tablet, and hence can be used as its substitute.
Euglitol 25 mg Tablet
Abbott Healthcare Pvt. Ltd.
Glock 25 mg Tablet
Unichem Laboratories Ltd.
Glybloc 25 mg Tablet
Unichem Laboratories Ltd.
Miglit 25 mg Tablet
Biocon Ltd.
Minerva (Mano) 25 mg Tablet
Orchid Chemicals & Pharmaceuticals Ltd.

Find a doctor near you

Looking for a doctor?

Book an appointment with the top doctors near you.

When not to use?

Contraindications of Mignar 25 mg Tablet

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to miglitol.

  • Diabetic ketoacidosis

    This medicine is not recommended for use in patients with a known history of Diabetic ketoacidosis, a life-threatening complication of diabetes mellitus.

  • Inflammatory bowel disease

    Mignar 25 mg Tablet is not recommended for use in patients with a known history of Inflammatory bowel disease.

  • Intestinal Obstruction

    This medicine is not recommended for use in patients with a known history of Intestinal Obstruction.

  • Chronic intestinal diseases

    This medicine is not recommended for use in patients with a known history of Chronic intestinal diseases.

Dosage

  • Missed Dose

    Take the missed dose as soon as you remember it. If it is almost time for your next scheduled dose, skip the missed dose. Do not double the dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcoholmoderate

  • Description

    - N/A

  • Instructions

    - Consumption of alcohol is not recommended during treatment with Mignar 25 mg Tablet due to the increased risk of both low as well as high blood sugar levels. If your diabetes is controlled, moderate consumption of alcohol does not affect sugar levels. However, it is advised that you consult your doctor about all the potential risks and benefits of consuming alcohol during treatment with this medicine.

Interaction with Medicine

  • Corticosteroidsmoderate
  • Furosemidemoderate
  • Gatifloxacinsevere

Disease interactions

  • Diabetic Ketoacidosis

    severe
    Mignar 25 mg Tablet is not recommended for use in patients with diabetic ketoacidosis. An alternative treatment option should be considered based on the clinical condition of the patient.

  • Gastro-intestinal disease

    severe
    Mignar 25 mg Tablet is not recommended for use in patients with inflammatory bowel disease or any chronic intestinal disease. An alternative treatment option should be considered based on the clinical condition. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.

Food interactions

  • Information not available.

Lab interactions

  • Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take Mignar 25 mg Tablet exactly as prescribed by the doctor. The dose of the medicine is likely to change based on your body's response to therapy. It is advisable to undergo blood sugar tests at regular intervals to safely use this medicine. You should always carry a sugar candy with you to overcome unexpected lowering of blood sugar levels. The schedule and duration of use should not be changed without consulting the doctor. Ensure that the course of treatment is completed. Report any adverse effects to the doctor on priority.

Warnings

Warnings for special population

  • Pregnancy

    - This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Breast-feeding

    - This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

General warnings

  • Low blood glucose levels

    - This medicine should be used with caution due to an increased risk of low blood glucose levels. This risk is especially higher in patients on other anti-diabetic medicines. Frequent monitoring of blood glucose levels is necessary during treatment with this medicine. Appropriate dose adjustments may be done based on the clinical condition.

  • Gastrointestinal disease

    - Mignar 25 mg Tablet is not recommended for use in patients with any gastrointestinal diseases like inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or any chronic intestinal disease. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.

Other details

  • To be taken with food
  • To be taken as instructed by doctor
  • Does not cause sleepiness

How it works

Mignar 25 mg Tablet works by lowering the blood sugar levels in diabetic patients.

Legal Status

Approved
Approved
Approved
Approved

Classification

Category
Alpha-glucosidase inhibitors
Schedule
Schedule H

References

Chat with a doctor

Get reply within 5 mins

How will this medicine affect me?

Chat with verified doctors starting @ ₹99

Did you find this helpful?

Your feedback will help us improve the product

Thanks for your response
What can we improve?
Thanks for your response
Information on this page was last updated on 10 Aug 2017

Report an error

Oops! Seems like there is an error in your form. Make sure -
  1. Your email ID is correct.
  2. Your response is not blank.
  3. Your internet is working.
Thank you!
Your response is valuable to us.

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.